Progenics Pharma (PGNX) Presents Data on Two Compounds Shown to Block Growth and Survival of Cancer Cells
Tweet Send to a Friend
Progenics Pharmaceuticals, Inc. (NASDAQ: PGNX) today announced the presentation of preclinical data on a series of novel compounds that simultaneously ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
